InvestorsHub Logo
Followers 20
Posts 2595
Boards Moderated 0
Alias Born 01/27/2022

Re: Nukemtiltheyglow post# 409789

Tuesday, 05/30/2023 1:10:59 PM

Tuesday, May 30, 2023 1:10:59 PM

Post# of 426232

Boy, you really think highly of yourself. First, your absolutely sure Sarissa and company don’t know a thing about the EU.

Now, you’re an expert on Alzheimer’s and the results on Brave are not going to show efficacy.

Remind me to go the opposite direction when you make a prediction.



Geez, Nuke, no need to be salty. I am just making some assumptions. I wasn't calling myself an "expert" on ALZ. I was stating what I think needs to happen to really juice the stock price. And yes, I don't think BRAVE is going to show "outstanding" results. But I think it will be positive. And I also don't think it will be the "answer" to ALZ (which is exactly what I stated). But that certainly doesn't make me an "expert". It's just an opinion - like the thing that every poster on this board has.

I would be doing backflips if I was wrong and the BRAVE trial is a raging success.

What we really need to hope for is that BRAVE results are good enough that it creates some interest/excitement/sense of urgency around Vascepa. That could be enough to juice the stock price and encourage a BO. And I'm not necessarily saying that IPE is the "answer" to ALZ. I actually don't think it is.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News